Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/detail.php on line 234

Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 82

Warning: array_push() expects parameter 1 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 85
Pharmalicensing | Life Science's Global Technology Marketplace
Save this technology
close
Save to Existing Project
Save to a New Project
Anti-Inflammatory Agent Showing Excellent Early Promise in Eye Models for Uveitis
Formuli United Kingdom flag United Kingdom
Abstract ID:
Recently gaining patent approval, this product is for Uveitis and Irritable Bowel Syndrome....
Contact Russ Pendleton
Participants
You
Email me a copy of this message
MECHANISM OF ACTION
Low down the inflammatory cascade.

Considerable in-vitro data has been generated showing this product to have excellent potential as an anti-inflammatory agent.  The company have selected Uveitis as a target indication and have Irritable Bowel Syndrome as a follow-up.


Looking for partners to move into the clinic.


 

Type of Business Relationship Sought
Funding, joint-venture, out-licensing
FEATURED
Last Updated Aug 2016
Technology Type MECHANISM
Phase of Development PRECLINICAL
CORPORATION